Highlights Newsletter 1
This newsletter presents you the following key sessions:
5. Rapid and durable responses with rilzabrutinib in the treatment of immune thrombocytopenia
This newsletter presents you the following key sessions:
5. Rapid and durable responses with rilzabrutinib in the treatment of immune thrombocytopenia
Medical writer
Medical writer